TP53 Mutational Status-Based Genomic Signature for Prognosis and Predicting Therapeutic Response in Pancreatic Cancer

TP53 mutation is a critical driver mutation that affects the carcinogenesis and prognosis of patients with pancreatic cancer (PC). Currently, there is no driver mutation-derived signature based on TP53 mutational status for prognosis and predicting therapeutic response in PC. In the present study, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng, Zhong, Wenhui, Li, Honghao, Huang, Kaijun, Yu, Min, Liu, Yubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187932/
https://www.ncbi.nlm.nih.gov/pubmed/34124046
http://dx.doi.org/10.3389/fcell.2021.665265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187932/
https://www.ncbi.nlm.nih.gov/pubmed/34124046
http://dx.doi.org/10.3389/fcell.2021.665265

Ejemplares similares